Keyword: emerging markets

News

US Foreign Bribery Penalties for Drugmakers May Lack Bite

29.10.2012 - Global drugmakers are paying tens of millions of dollars to settle U.S. allegations that they bribed their way across emerging markets, but harsher penalties may be needed to deter...

Logistics & Supply Chain

Supply chain management organisations developing towards a coordinated network model

25.09.2012 - The rise of new markets throughout the world means that all globally active companies must continuously adapt to the developing changes. Ultimately, change never comes to an end...

Chemistry & Life Sciences

M&A in the Chemicals & Materials Sector in the First Half of 2012

25.09.2012 - Mergers & Acquisitions - Recently, Squire Sanders commissioned a report from their partners at Mergermarket on mergers and acquisitions activity in the chemicals and industrials...

News

Small Generic Drug Firms Need Niches to Survive Looming Price War

21.07.2012 - Aggressive consolidation among U.S. and European generic drugmakers is putting pressure on smaller competitors in the industry, whose best hope of surviving a brewing price war may...

Chemistry & Life Sciences

The Pharmaceutical Supply Chain

19.07.2012 - Mean and Lean - The pharmaceutical supply chain has gone through a dramatic transformation over the past few decades, with an ever-increasing number of players involved in...

News

Generics Seen Cutting into Drug Sales Growth through 2016

12.07.2012 - Annual global spending on prescription drugs will rise 25% by 2016 to $1.2 trillion, as surging growth in emerging markets eclipses weak gains in developed markets like the United...

News

India to Give Free Generic Drugs to Hundreds of Millions

05.07.2012 - India has put in place a $5.4 billion policy to provide free medicine to its people, a decision that could change the lives of hundreds of millions, but a ban on branded drugs...

News

China Changes Patent Law in Fight for Cheaper Drugs

09.06.2012 - China has overhauled parts of its intellectual property laws to allow its drugmakers to make cheap copies of medicines still under patent protection in an initiative likely to...